Article Details

Merck KGaA and Mersana partner in potential $830m deal - PMLiVE

Retrieved on: 2023-01-04 00:54:43

Tags for this article:

Click the tags to see associated articles and topics

Merck KGaA and Mersana partner in potential $830m deal - PMLiVE. View article details on hiswai:

Excerpt

The companies will work together to develop novel antibody-drug conjugates ... ADCs combine the targeting properties of monoclonal antibodies with ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up